Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > hello

<< Previous

Bullboard Posts

Next >>

Comment by Renofundon Jun 06, 2022 3:23pm

130 Views

Post# 34735004

RE:hello

JensLens wrote: Here are my predictions

Milman will owe an apology to all the longterm shareholders if they ever have good results from the trials

We now have a phase 2 IND submitted that is factual.

3 drug candidates

MS drug has huge potential

huh? how is that a prediction? You are reqesting an apology, not predicting one. And you aren't predicting results, seeing as you said "if". Once again, you make no sense LOL.

was away from these boards for a few months. hilarious to see nothing has changed, excpet for Rosie's screen name of course.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023